• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Natera, Inc. - Common Stock (NQ:NTRA)

    224.46 +12.61 (+5.95%)
    Streaming Delayed Price Updated: 2:55 PM EDT, Jun 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 738,882
    Open 213.95
    Bid (Size) 224.11 (200)
    Ask (Size) 224.97 (100)
    Prev. Close 211.85
    Today's Range 212.17 - 227.90
    52wk Range 131.81 - 256.36
    Shares Outstanding 139,693,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer
    From Natera, Inc.
    Via Business Wire
    News headline image
    Here's Billionaire Stanley Druckenmiller's Top Holding (Hint: It's Not Alphabet or Nvidia) ↗
    The famous hedge fund manager seems to have found a hidden gem outside of the market's most popular stock picks. 
    Via The Motley Fool

    Performance

    YTD
    -1.9%
    -1.9%
    1 Month
    +6.1%
    +6.1%
    3 Month
    +10.6%
    +10.6%
    6 Month
    -5.8%
    -5.8%
    1 Year
    +40.2%
    +40.2%

    More News

    Read More
    News headline image
    Natera Appoints Oncology Leaders Drs. Thomas Lynch and Eric Rubin to Board of Directors
    From Natera, Inc.
    Via Business Wire
    News headline image
    NWI Management Dumps 42,700 MercadoLibre Shares Worth $82.4 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Natera (NTRA) Q1 Revenue Beat Overshadowed by EPS Miss and Operating Losses ↗
    Via Chartmill
    News headline image
    Natera Announces Collaboration with Diakonos Oncology for Signatera™ in Refractory Melanoma
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera Enrolls First Patients in SIGNAL-ER 101, a Prospective, Interventional Study Evaluating MRD-Guided Therapy in Breast Cancer
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera to Launch Enhanced Panorama™ NIPT, Powered by Novel SNP-Informed Deep Sequencing Technology
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera Announces Expansion in Austin, Creating What Is Believed to Be the Largest Sequencing Facility in the World
    From Natera, Inc.
    Via Business Wire
    News headline image
    EXPAND Trial of Natera’s Fetal Focus™ Single-Gene NIPT Surpasses >2,000 Patients Enrolled
    From Natera, Inc.
    Via Business Wire
    News headline image
    1 Mid-Cap Stock with Exciting Potential and 2 That Underwhelm
    Via StockStory
    News headline image
    5 Must-Read Analyst Questions From Natera’s Q1 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    Why Natera (NTRA) Shares Are Plunging Today
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    Natera Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    NTRA Q1 Deep Dive: Robust Volume Growth and Product Expansion Shape Outlook
    Via StockStory
    News headline image
    Natera NTRA Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Natera’s (NASDAQ:NTRA) Q1 CY2026 Sales Top Estimates
    Via StockStory
    News headline image
    Natera Reports First Quarter 2026 Financial Results
    From Natera, Inc.
    Via Business Wire
    News headline image
    What To Expect From Natera’s (NTRA) Q4 Earnings
    Via StockStory
    News headline image
    Natera to Report its First Quarter Results on May 7, 2026
    From Natera, Inc.
    Via Business Wire
    News headline image
    Prospera™ Evidence in Heart and Lung Transplantation Featured Across 17 Presentations at ISHLT
    From Natera, Inc.
    Via Business Wire
    News headline image
    Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    3 Reasons We’re Fans of Natera (NTRA)
    Via StockStory
    Topics Stocks
    News headline image
    Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know
    Via StockStory
    Topics Economy Government Stocks

    Frequently Asked Questions

    Is Natera, Inc. - Common Stock publicly traded?
    Yes, Natera, Inc. - Common Stock is publicly traded.
    What exchange does Natera, Inc. - Common Stock trade on?
    Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Natera, Inc. - Common Stock?
    The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
    What is the current price of Natera, Inc. - Common Stock?
    The current price of Natera, Inc. - Common Stock is 224.46
    When was Natera, Inc. - Common Stock last traded?
    The last trade of Natera, Inc. - Common Stock was at 06/04/26 02:55 PM ET
    What is the market capitalization of Natera, Inc. - Common Stock?
    The market capitalization of Natera, Inc. - Common Stock is 31.36B
    How many shares of Natera, Inc. - Common Stock are outstanding?
    Natera, Inc. - Common Stock has 31B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.